Clinical Professor of Dermatology, Yale University
Dermatology
Dr. Ronald C. Savin, MD
|
|
Give Review
Ronald Savin works in the field of Dermatology. He studied medicine at University of Florida College of Medicine. University of Florida College of Medicine is ranked 43 in research and 78 in primary care medicine Ronald Savin is also a published physician. He has 68 paper published. The most recent paper is: Severe urticarial reaction to diphenylcyclopropenone therapy for alopecia areata. Doctor Ronald C. Savin, MD is registered with Medicare and accepts Medicare payments.
Publications
- Evaluation of the efficacy and safety of clobetasol propionate spray in the treatment of plaque-type Psoriasis.
- A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern Hair loss.
- Ciclopirox gel in the treatment of patients with interdigital Tinea pedis.
- Ciclopirox gel for seborrheic Dermatitis of the scalp.
- Double-blind, randomized, vehicle-controlled clinical trial of once-daily benzoyl peroxide/clindamycin topical gel in the treatment of patients with moderate to severe...
- Long-term efficacy and safety of tretinoin emollient cream 0.05% in the treatment of photodamaged facial Skin: a two-year, randomized, placebo-controlled trial.
- The safety and efficacy of sertaconazole nitrate cream 2% for Tinea pedis.
- A systemic type I 5 alpha-reductase inhibitor is ineffective in the treatment of Acne vulgaris.
- Randomized trial evaluating a new 0.5% fluorouracil formulation demonstrates efficacy after 1-, 2-, or 4-week treatment in patients with Actinic keratosis.
- Efficacy and tolerability of finasteride 1 mg in men aged 41 to 60 years with male pattern Hair loss.
- Aggressive Acne treatment: as simple as one, two, three?
- Tretinoin emollient cream for photodamaged Skin: results of 48-week, multicenter, double-blind studies.
- Sustained improvement in photodamaged Skin with reduced tretinoin emollient cream treatment regimen: effect of once-weekly and three-times-weekly applications.
- Oral terbinafine in the treatment of toeNail onychomycosis: North American multicenter trial.
- Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toeNail.
- Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the fingerNail.
- Pharmacokinetics of three doses of once-weekly fluconazole (150, 300, and 450 mg) in distal subungual onychomycosis of the toeNail.
- Pharmacokinetics of three once-weekly dosages of fluconazole (150, 300, or 450 mg) in distal subungual onychomycosis of the fingerNail.
- Ketoconazole 2% shampoo in the treatment of Tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial.
- Prevalence of male pattern Hair loss in 18-49 year old men.
- Severe urticarial reaction to diphenylcyclopropenone therapy for alopecia areata.
- Efficacy and safety of terbinafine 1% solution in the treatment of interdigital Tinea pedis and Tinea corporis or Tinea cruris.
- Letter: Patch testing of coolant fractions.
- Photochemotherapy for Psoriasis--PUVA breaking through "the heartbreak".
- Desoximetasone--a new topical corticosteroid: short- and long-term experiences.
- Are Hair transplants successful?
- Halcinonide, a new topical anti-inflammatory steroid.
- Betamethasone dipropionate in psoriasis and atopic Dermatitis.
- Inocoterone and Acne. The effect of a topical antiandrogen: results of a multicenter clinical trial.
- Comparative efficacy of oral erythromycin versus oral tetracycline in the treatment of Acne vulgaris.
- Malignant blue nevus. Case report and literature review.
- A comparison of clobetasol propionate 0.05 percent ointment and an optimized betamethasone dipropionate 0.05 percent ointment in the treatment of Psoriasis.
- Multicentre double-blind clinical trials of ciclopirox olamine cream 1% in the treatment of Tinea corporis and Tinea cruris.
- Use of topical minoxidil in the treatment of male pattern baldness.
- Double-blind comparison of 2% ketoconazole cream and placebo in the treatment of Tinea versicolor.
- Hyperglobulinemic purpura terminating in myeloma, hyperlipemia, and xanthomatosis.
- Antibiotics and the placebo reaction in Acne.
- Hair transplants in burn scars and other alopecias.
- The ineffectiveness of testosterone in male pattern baldness.
- Hair transplantation.
- Auricular Cancer. Some surgical and pathologic considerations.
- Topical tretinoin for treatment of photodamaged Skin. A multicenter study.
- Treatment of chronic tinea pedis (athlete's Foot type) with topical terbinafine.
- Treatment of chronic moccasin-type Tinea pedis with terbinafine: a double-blind, placebo-controlled trial.
- Oral terbinafine versus griseofulvin in the treatment of moccasin-type Tinea pedis.
- Malignant atrophic papulosis. (Degos'' syndrome).
- Systemic ketoconazole in Tinea versicolor: a double-blind evaluation and 1-year follow-up.
- Severely dry Skin: clinical evaluation of a highly effective therapeutic lotion.
- The failure to preserve direct access to dermatology in the New Haven IPA.
- Psychological effects of androgenetic alopecia on women: comparisons with balding men and with female control subjects.
- Minoxidil. Update on its clinical role.
- Terbinafine in onychomycosis--a mini study.
- Efficacy of terbinafine 1% cream in the treatment of moccasin-type Tinea pedis: results of placebo-controlled multicenter trials.
- One-week therapy with twice-daily butenafine 1% cream versus vehicle in the treatment of Tinea pedis: a multicenter, double-blind trial.
- Tinea versicolor treated with terbinafine 1% solution.
- Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group.
- Tretinoin cream 0.02% for the treatment of photodamaged facial Skin: a review of 2 double-blind clinical studies.
- Topical terbinafine and clotrimazole in interdigital Tinea pedis: a multicenter comparison of cure and relapse rates with 1- and 4-week treatment regimens.
- Long-term outcome of patients with interdigital Tinea pedis treated with terbinafine or clotrimazole.
- Efficacy of a 1-week, twice-daily regimen of terbinafine 1% cream in the treatment of interdigital Tinea pedis. Results of placebo-controlled, double-blind, multicente...
- Clinical dose ranging studies with finasteride, a type 2 5alpha-reductase inhibitor, in men with male pattern Hair loss.
- Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia.
- Diagnosis and treatment of Tinea versicolor.
- Successful treatment of chronic Tinea pedis (moccasin type) with terbinafine (Lamisil).
- The Basal cell nevus syndrome and inflammatory disease of the bowel.
- [Incontinentia pigmenti (Bloch-Sulzberger syndrome). Appraisal of 2 cases].
- [Primary hyperlipoproteinemias in children].
Schools
University Of Florida
Jackson Memorial Hospital
Yale Hospital
Procedures Preformed
- Destruction of Benign Skin Lesion
- Destruction of Malignant Skin Lesion
- Excision of Benign Skin Lesion
- Shaving of Skin Lesion
Conditions Treated
- Acne
- Actinic Keratosis
- Athlete's Foot
- Basal Cell Carcinoma
- View All
Doctors Specialties
- Dermatology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Pathway X Ind PPO Direct Access CT
- Blue Card PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Connecticare HMO
- Connecticare POS
- CoreSource
- Health Insurance Plan of Greater New York (HIP) PPO
- Golden Rule
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- National Elevator
- Freedom Plan
- Tricare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- Oxford Liberty
- United Healthcare
Education
-
Yale-New Haven Hospital -
Jackson Memorial Hospital - Jackson Health System -
University of Florida College of Medicine
Hospital
-
Yale-New Haven Hospital
Drug Facts
| NPI NUMBER | 1366482846 | |
| NPPES Provider LastName | SAVIN | |
| NPPES Provider FirstName | RONALD | |
| NPPES Provider ZIPCode | 065115409 | |
| NPPES Provider State | CT | |
| Specialty Description | Dermatology | |
| Total Claim Count | 508.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1366482846 |
| Last Name Of The Provider | SAVIN |
| First Name Of The Provider | RONALD |
| View All |
Similar Doctors
|
|
Dr. Jennifer N. Choi, MD |
|
|
Dr. Sean R. Christensen, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John W. Edelglass, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marcus Bosenberg, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Samuel E. Book, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert E. Tigelaar, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Mary M. Tomayko, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael Girardi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shelly Rivas, MD |